CVA Family Office, LLC
Family OfficePosition in GLSI — Greenwich LifeSciences, Inc.
CIK 1802084
DENVER, CO
Position in GLSI
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$240
New position
Shares Held
10
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026CVA Family Office, LLC holds $673,454 across 40 Biotechnology names. GLSI ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
472 | $210,766 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
194 | $149,892 | |
| 3 | MRNA |
Moderna, Inc.
|
1,701 | $86,410 | |
| 4 | INCY |
Incyte Corp
|
904 | $85,084 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
92 | $30,440 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
84 | $15,880 | |
| 7 | EXEL |
Exelixis, Inc.
|
270 | $11,580 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
146 | $10,841 |
All Filings in GLSI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $240 | 10 | Shares | Sole | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||